The Octreotide Acetate Injection, cataloged under National Stock Number 6505-01-372-3426, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-372-3426 |
| Primary Part Number | NDC63323-0379-05 |
| Item Name | Octreotide Acetate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 5.000 MILLILITERS |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Protective Storage Feature | SUBJECT TO DAMAGE BY FREEZING |
| Active Medicament Medicinal Strength | 1000.000 MICROGRAMS OCTREOTIDE ACETATE PER MILLILITER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0379-05 PRIMARY | Fresenius Kabi, Llc (USA) |
| Reference | Meaning |
|---|---|
| SANDOSTATIN | 5/1 Secondary reference Novartis Pharmaceuticals Corporation |
| A93A038 | 5/1 Secondary reference Department of the Army U S Army Medical Material Agency Mcmr-Mmo-Sa |
NSN 6505-01-372-3426 is a Octreotide Acetate Injection, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-372-3426 has 1 manufacturer part number on file: NDC63323-0379-05 (Fresenius Kabi, Llc).
Key specifications for NDC63323-0379-05: Primary Container Content Quantity: 5.000 MILLILITERS; Primary Container Type: VIAL, MULTIPLE DOSE; Protective Storage Feature: SUBJECT TO DAMAGE BY FREEZING; Part Name Assigned by Controlling Agency: OCTREOTIDE ACETATE INJECTION 1000MCG/ML 5ML VIAL. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.